Head-To-Head Comparison: Envoy Medical (COCH) & The Competition

Envoy Medical (NASDAQ:COCH) is one of 51 public companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Envoy Medical to similar companies based on the strength of its analyst recommendations, earnings, profitability, dividends, institutional ownership, valuation and risk.

Institutional and Insider Ownership

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 60.5% of Envoy Medical shares are owned by company insiders. Comparatively, 10.2% of shares of all “Surgical appliances & supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Envoy Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-7,607.55%	N/A	-262.28%
Envoy Medical Competitors	-169.94%	-74.14%	-20.85%

Analyst Recommendations

This is a summary of recent ratings and target prices for Envoy Medical and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Envoy Medical Competitors	400	1401	2525	116	2.53

Envoy Medical presently has a consensus price target of $9.00, indicating a potential upside of 592.31%. As a group, “Surgical appliances & supplies” companies have a potential upside of 45.08%. Given Envoy Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than its competitors.

Volatility and Risk

Envoy Medical has a beta of 2.35, indicating that its share price is 135% more volatile than the S&P 500. Comparatively, Envoy Medical’s competitors have a beta of 1.27, indicating that their average share price is 27% more volatile than the S&P 500.

Earnings and Valuation

This table compares Envoy Medical and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$225,000.00	-$29.91 million	-0.92
Envoy Medical Competitors	$1.41 billion	$234.66 million	14.08

Envoy Medical’s competitors have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Envoy Medical competitors beat Envoy Medical on 7 of the 13 factors compared.

Envoy Medical Company Profile

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.